Global Market Direct’s pharmaceuticals report, “Cytheris SA - Product Pipeline Review - 2013” provides data on the Cytheris SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cytheris SA’s corporate website, SEC filings, investor presentations and featured press releases, both from Cytheris SA and industry-specific third party sources, put together by Global Markets Direct’s team.
- Cytheris SA - Brief Cytheris SA overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Cytheris SA human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Cytheris SA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Cytheris SA’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Cytheris SA’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Cytheris SA in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Cytheris SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Cytheris SA. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Cytheris SA and identify potential opportunities in those areas.
Table Of Contents
Cytheris SA - Product Pipeline Review - 2013 Table of Contents 2 List of Tables 3 List of Figures 3 Cytheris SA Snapshot 4 Cytheris SA Overview 4 Key Information 4 Key Facts 4 Cytheris SA - Research and Development Overview 5 Key Therapeutic Areas 5 Cytheris SA - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Cytheris SA - Pipeline Products Glance 9 Cytheris SA Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Cytheris SA - Early Stage Pipeline Products 11 Pre-Clinical Products/Combination Treatment Modalities 11 Cytheris SA - Drug Profiles 12 CYT-107 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 CYT-209 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 CYT-99 007 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 Cytheris SA - Pipeline Analysis 17 Cytheris SA - Pipeline Products by Therapeutic Class 17 Cytheris SA - Pipeline Products by Route of Administration 18 Cytheris SA - Pipeline Products By Mechanism of Action 19 Cytheris SA - Recent Pipeline Updates 20 Cytheris SA - Dormant Projects 22 Cytheris SA - Locations And Subsidiaries 23 Head Office 23 Other Locations and Subsidiaries 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 25 Disclaimer 25
List of Tables
Cytheris SA, Key Information 4 Cytheris SA, Key Facts 4 Cytheris SA - Pipeline by Indication, 2013 6 Cytheris SA - Pipeline by Stage of Development, 2013 7 Cytheris SA - Monotherapy Products in Pipeline, 2013 8 Cytheris SA - Phase II, 2013 9 Cytheris SA - Phase I, 2013 10 Cytheris SA - Pre-Clinical, 2013 11 Cytheris SA - Pipeline By Therapeutic Class, 2013 17 Cytheris SA - Pipeline By Route of Administration, 2013 18 Cytheris SA - Pipeline Products By Mechanism of Action, 2013 19 Cytheris SA - Recent Pipeline Updates, 2013 20 Cytheris SA - Dormant Developmental Projects,2013 22 Cytheris SA, Subsidiaries 23
List of Figures
Cytheris SA - Pipeline by Indication, 2013 6 Cytheris SA - Pipeline by Stage of Development, 2013 7 Cytheris SA - Monotherapy Products in Pipeline, 2013 8 Cytheris SA - Pipeline By Therapeutic Class, 2013 17 Cytheris SA - Pipeline By Route of Administration, 2013 18 Cytheris SA - Pipeline Products By Mechanism of Action, 2013 19